Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiora Pharmaceuticals (KPRX) Short-term Investments (2024 - 2025)

Kiora Pharmaceuticals' Short-term Investments history spans 2 years, with the latest figure at $8.4 million for Q4 2025.

  • For Q4 2025, Short-term Investments fell 63.51% year-over-year to $8.4 million; the TTM value through Dec 2025 reached $8.4 million, down 63.51%, while the annual FY2025 figure was $8.4 million, 63.51% down from the prior year.
  • Short-term Investments reached $8.4 million in Q4 2025 per KPRX's latest filing, down from $13.9 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $23.4 million in Q3 2024 to a low of $8.4 million in Q4 2025.